J3490 is unclassified drugs, billed at Per administration — quantity billed as supplied. It covers Dupixent, Mounjaro, Ozempic, Wegovy, Zepbound (Dupilumab, Semaglutide, Tirzepatide).
J3490 is a miscellaneous code. Payers require the 11-digit NDC, the quantity administered with a unit qualifier, the drug name and strength, and usually a copy of the acquisition invoice. Claims without those details are rejected as unpriceable rather than denied on medical necessity.
5 brand names and 3 generics map to this code.
Unclassified biologics / Dupilumab
Unclassified biologics / Dupilumab
Unclassified drugs / Tirzepatide (Mounjaro)
Unclassified biologics / Semaglutide (Ozempic)
Unclassified biologics / Semaglutide
Unclassified drugs / Tirzepatide
Unclassified biologics / Semaglutide (Wegovy)
Unclassified drugs / Tirzepatide (Zepbound)
HCPCS Level II is updated quarterly by CMS. Verify J3490 against the current release before submitting a high-value claim.